Alcohol-related diseases: from metabolism to the main effect on the body.


Journal

Minerva medica
ISSN: 1827-1669
Titre abrégé: Minerva Med
Pays: Italy
ID NLM: 0400732

Informations de publication

Date de publication:
13 Jun 2024
Historique:
medline: 13 6 2024
pubmed: 13 6 2024
entrez: 13 6 2024
Statut: aheadofprint

Résumé

Alcohol consumption can cause, beyond addiction, roughly 200 different diseases and at least fourteen types of cancer. In 2016 the WHO estimated that 29% of alcohol-related deaths were mainly due to oncological diseases, liver cirrhosis (20%), and cardiovascular disorders (19%). The aim of this review was to focus on the absorption and metabolism of ethanol and discuss the main conditions caused by alcohol consumption (i.e., liver and cardiovascular diseases, and tumors). This narrative review is based on a detailed analysis of the scientific literature published before January 31, 2024 (PubMed, Web of Science, Scopus, Google Scholar). Approximately 90% of the absorbed alcohol reaches the liver where it is metabolized to acetaldehyde, a highly reactive and toxic compound. The excessive use of alcohol causes damage to several organs and systems, mainly the liver (e.g., steatosis, steato-hepatitis, fibrosis, and cirrhosis), cardiovascular system (cardiomyopathy, arrythmias, arterial hypertension, and stroke), and significantly contribute to the onset of neoplastic lesions to various organs including the esophagus, liver and breast. Even moderate drinking appears not to reduce mortality risk. Alcohol intake is one of the main risk factors for several pathological conditions and social problems, thus drastically impacting on public health. Proper awareness of the high risk related to alcohol consumption is of crucial importance to reduce the harm to public health.

Identifiants

pubmed: 38867598
pii: S0026-4806.24.09355-8
doi: 10.23736/S0026-4806.24.09355-8
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Fabio Caputo (F)

Department of Translational Medicine, Center for the Study and Treatment of Alcohol-Related Diseases, University of Ferrara, Ferrara, Italy - fabio.caputo@unife.it.
Department of Internal Medicine, SS Annunziata Hospital, University of Ferrara, Cento, Ferrara, Italy - fabio.caputo@unife.it.

Lisa Lungaro (L)

Department of Translational Medicine, University of Ferrara, Ferrara, Italy.

Matteo Guarino (M)

Department of Translational Medicine, University of Ferrara, Ferrara, Italy.
Department of Emergency, S. Anna University Hospital, Ferrara, Italy.

Anna Costanzini (A)

Department of Translational Medicine, University of Ferrara, Ferrara, Italy.

Giacomo Caio (G)

Department of Translational Medicine, Center for the Study and Treatment of Alcohol-Related Diseases, University of Ferrara, Ferrara, Italy.
Department of Translational Medicine, University of Ferrara, Ferrara, Italy.

Gianni Testino (G)

Unit of Addiction and Hepatology, San Martino Polyclinic Hospital, ASL3, Genoa, Italy.

Roberto DE Giorgio (R)

Department of Translational Medicine, Center for the Study and Treatment of Alcohol-Related Diseases, University of Ferrara, Ferrara, Italy.
Department of Translational Medicine, University of Ferrara, Ferrara, Italy.

Classifications MeSH